TNA
YDESW

True North Advisors’s YD Bio Ltd Warrants YDESW Stock Holding History

True North Advisors’s Portfolio YDESW Stock Details YDESW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$68.5K Hold
220,819
– – 0.01% 290
2026
Q1 		$144K Sell
220,819
-200
-0.1% -$170 0.02% 245
2025
Q4 		$219K Buy
221,019
+1,999
+0.9% +$2.82K 0.03% 239
2025
Q3 		$467K Buy
+219,020
New +$382K 0.07% 137

Other funds holding YDESW

CCMW
Cypress Capital Management (Wyoming) Sheridan, Wyoming $120M AUM 63.01% 1-Year Est. Return
OMC
Oasis Management Company Grand Cayman, Cayman Islands $1.88B AUM 54.21% 1-Year Est. Return
Cerity Partners
Cerity Partners New York $82.7B AUM 28.53% 1-Year Est. Return
CS
Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $7.69B AUM 15.48% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
CIA
Concurrent Investment Advisors Tampa, Florida $11.8B AUM 31.86% 1-Year Est. Return

True North Advisors's YDESW Position: Q2 2026 in Review

True North Advisors held its YD Bio Ltd Warrants (YDESW) position steady in Q2 2026 at 220,819 shares worth $68.5K. The position accounts for 0.01% of the portfolio, ranked #290.

True North Advisors first reported a position in YDESW in Q3 2025 and has held it in 4 quarters since. The position peaked at $467K in Q3 2025. 8 funds tracked by Wall St. Rank hold YDESW as of Q2 2026.

  • True North Advisors held 220,819 shares of YD Bio Ltd Warrants worth $68.5K as of Q2 2026.
  • True North Advisors left its YD Bio Ltd Warrants share count unchanged in Q2 2026.
  • YD Bio Ltd Warrants made up 0.01% of True North Advisors's portfolio in Q2 2026, its #290 holding.
  • True North Advisors first reported a position in YD Bio Ltd Warrants in Q3 2025 and has held it in 4 quarters since.
  • True North Advisors's YD Bio Ltd Warrants position peaked at $467K in Q3 2025.
  • 8 funds tracked by Wall St. Rank held YD Bio Ltd Warrants as of Q2 2026.

Based on True North Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.